good volume and still plenty of value left in the spcant wait to see where she blows when the tibotec deal is announcedoh, and followed by the phiii data and partner...glta
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago